Li Xiao

475 total citations
16 papers, 328 citations indexed

About

Li Xiao is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Li Xiao has authored 16 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Epidemiology. Recurrent topics in Li Xiao's work include Liver Disease Diagnosis and Treatment (3 papers), Hedgehog Signaling Pathway Studies (2 papers) and Tea Polyphenols and Effects (2 papers). Li Xiao is often cited by papers focused on Liver Disease Diagnosis and Treatment (3 papers), Hedgehog Signaling Pathway Studies (2 papers) and Tea Polyphenols and Effects (2 papers). Li Xiao collaborates with scholars based in China, United States and Germany. Li Xiao's co-authors include Ling Yang, Qingjing Zhu, Wenfang Gui, Xiaohua Hou, Jinfang Zhao, Huikuan Chu, Fan Du, Bernd Schnabl, Dan Sun and Kai Huang and has published in prestigious journals such as Hepatology, British Journal of Pharmacology and Journal of Leukocyte Biology.

In The Last Decade

Li Xiao

15 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Xiao China 8 130 94 61 61 57 16 328
Evan G. Pappas Australia 9 146 1.1× 70 0.7× 78 1.3× 50 0.8× 55 1.0× 15 407
Rilu Feng China 11 183 1.4× 73 0.8× 82 1.3× 50 0.8× 23 0.4× 21 360
Jihoon Shin Japan 11 100 0.8× 96 1.0× 49 0.8× 104 1.7× 26 0.5× 16 348
Ewelina Józefczuk Poland 8 198 1.5× 51 0.5× 31 0.5× 51 0.8× 47 0.8× 12 412
Min Cheng China 13 102 0.8× 87 0.9× 35 0.6× 28 0.5× 42 0.7× 31 380
Ivana Němečková Czechia 12 125 1.0× 78 0.8× 40 0.7× 71 1.2× 21 0.4× 24 369
Shinsuke Chida Japan 5 179 1.4× 88 0.9× 42 0.7× 54 0.9× 55 1.0× 7 522
Tonghai Xing China 14 123 0.9× 119 1.3× 118 1.9× 38 0.6× 53 0.9× 28 491

Countries citing papers authored by Li Xiao

Since Specialization
Citations

This map shows the geographic impact of Li Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Xiao more than expected).

Fields of papers citing papers by Li Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Xiao. The network helps show where Li Xiao may publish in the future.

Co-authorship network of co-authors of Li Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Li Xiao. A scholar is included among the top collaborators of Li Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Xiao. Li Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Wang, Tao, et al.. (2024). Prediction of the Quality of Anxi Tieguanyin Based on Hyperspectral Detection Technology. Foods. 13(24). 4126–4126. 3 indexed citations
3.
Zhang, Xuan, Chengbo Yu, Li Xiao, et al.. (2024). IRE1α inhibits osteogenic differentiation of mouse embryonic fibroblasts by limiting Shh signaling. Oral Diseases. 30(7). 4504–4517. 1 indexed citations
4.
Yu, Chengbo, Li Xiao, Zhixing Zhang, et al.. (2024). IRE1α pathway: A potential bone metabolism mediator. Cell Proliferation. 57(10). e13654–e13654. 5 indexed citations
5.
Liu, Zhixin, et al.. (2023). The Role of Gli1+ Mesenchymal Stem Cells in Osteogenesis of Craniofacial Bone. Biomolecules. 13(9). 1351–1351. 4 indexed citations
6.
Hu, Yue, Lili Yu, X Y Feng, et al.. (2021). Expression of bone morphogenetic protein 10 in cases with endometrial carcinoma and its clinical significance. Clinical & Translational Oncology. 23(8). 1711–1716. 1 indexed citations
9.
Wang, Chen, Jun Liu, Li Xiao, et al.. (2019). Comparison of FRAX in postmenopausal Asian women with and without type 2 diabetes mellitus: a retrospective observational study. Journal of International Medical Research. 48(2). 1219679143–1219679143. 7 indexed citations
10.
Wang, Weijun, et al.. (2018). Prognostic significance of CXCR7 in cancer patients: a meta-analysis. Cancer Cell International. 18(1). 212–212. 16 indexed citations
11.
Yang, Ling, Weijun Wang, Xiaozhan Wang, et al.. (2018). Creg in Hepatocytes Ameliorates Liver Ischemia/Reperfusion Injury in a TAK1‐Dependent Manner in Mice. Hepatology. 69(1). 294–313. 59 indexed citations
13.
Wang, Weijun, Jinfang Zhao, Wenfang Gui, et al.. (2017). Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non‐alcoholic fatty liver disease. British Journal of Pharmacology. 175(3). 469–484. 160 indexed citations
14.
Liu, Kui, Xiansheng Liu, Li Xiao, et al.. (2012). NADPH Oxidase Activation: A Mechanism of Erectile Dysfunction in a Rat Model of Sleep Apnea. Journal of Andrology. 33(6). 1186–1198. 22 indexed citations
15.
Chen, Hui, Li Xiao, Hailong Zhang, et al.. (2011). The involvement of β-actin in the signaling of transmembrane TNF-α-mediated cytotoxicity. Journal of Leukocyte Biology. 89(6). 917–926. 13 indexed citations
16.
Chen, Gang, Jing Li, Fujun Li, et al.. (2004). Inhibitory effects of anti-sense PTTG on malignant phenotype of human ovarian carcinoma cell line SK-OV-3. Current Medical Science. 24(4). 369–372. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026